Log In
Print this Print this

CAN04 (formerly Anti-IL-1RAP mAb)

  Manage Alerts
Collapse Summary General Information
Company Cantargia AB
DescriptionHumanized mAb targeting IL-1 receptor accessory protein (IL-1RAP)
Molecular Target Interleukin-1 (IL-1) receptor accessory protein (IL-1RAP)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today